You are here: All Products  > Antengene Closes $97 Million Round to Develop Hematology/Oncology Portfolio

Antengene Closes $97 Million Round to Develop Hematology/Oncology Portfolio

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.